Top

Tag: Valeant


News

Valeant cuts revenue forecast; makes progress on debt repayment

August 9, 2017

Via: CNBC

Canada’s Valeant Pharmaceuticals reported a better-than-expected quarterly profit and said it expected to repay more than $5 billion in debt earlier than it had targeted, sending its shares up 10 percent. Since taking the helm in April 2016, Joseph Papa has been […]


News

Tax benefit helps Valeant post quarterly profit vs year-ago loss

May 10, 2017

Via: CNBC

Canada’s Valeant Pharmaceuticals reported a first-quarter profit, compared with a year-ago loss, due to an income tax benefit, and the drugmaker also raised its full-year adjusted EBITDA forecast. Valeant’s U.S.-listed shares jumped about 12 percent in premarket trading on Tuesday. […]


Regulatory

Two Are Charged In Fraud And Kickback Scheme Against Valeant Pharmaceuticals

November 18, 2016

Via: Forbes

Gary Tanner and Andrew Davenport, the former CEO of Philidor Rx Services, have been arrested and charged with fraud. Preet Bharara, United States Attorney for the Southern District of New York, is accusing Tanner and Davenport of engaging in a […]


News

Valeant Pharmaceuticals And Zoetis: A True Mega Deal Is On The Horizon

June 26, 2015

Via: Forbes

Call it conspicuous consumption. Serial acquirer Valeant Pharmaceuticals, an anointed stock in the portfolios of some of the largest hedge funds in Manhattan, appears to be on the prowl for a new takeover after closing its $11 billion acquisition of […]